First ever 'off the shelf' stem cell therapy nears European approval
European regulators have recommended Alofisel a new advanced therapy to treat complex perianal fistulas in patients with Crohns disease.The treatment is now just a step away from being the first...
View ArticleEurope Injectable Drug Delivery Devices Market Analysis Companies Profiles...
The Europe Injectable Drug Delivery Market is accounted to reach USD 265.0 billion by 2024 from USD 107.4 billion in 2016 it is growing at a CAGR of 11.9 in the forecast period 2017 to 2024. The major...
View ArticlePfizer gets FDA nod for second Remicade biosimilar
David SalazarThe Food and Drug Administration recently approved Pfizer’s Ixifi infliximabqbtx the company’s second approved biosimilar of Janssen’s Remicade. The...
View ArticleDysfunctional gene may be culprit in some Crohn's disease cases
Scripps Research Institute The scientists hope understanding how immune cells adapt as they enter different tissues will spur the design of better more specific medicines.
View ArticleQu Biologics invited to present research data at inaugural Crohns and Colitis...
VANCOUVER British Columbia Dec. 19 2017 GLOBE NEWSWIRE Qu Biologics Inc. a biopharmaceutical company developing Site Specific Immunomodulators SSIs a unique platform of immunotherapies designed to...
View ArticleGalapagos to copromote JAK1 inhibitor if approved for IBD RA
Biotech company Galapagos has opted to copromote filgotinib with its partner Gilead Sciences should the drug be approved in Europe according to a press release.Filgotinib is an investigational oral...
View ArticleDysfunctional gene may be cause of Crohn's disease in some patients
This holiday season millions of people will gather at airports ready to board planes for destinations around the world. Depending on the environment at their destination their suitcases may be filled...
View ArticleTiGenix confirms strategic focus on Cx601 and its adipose derived stem cell...
PRESS RELEASE TiGenix confirms strategic focus on Cx601 and its adipose derived stem cell eASC platform Leuven BELGIUM December 20 2017 700h CET TiGenix NV Euronext Brussels and NASDAQ TIG...
View ArticleTxCell SA TXCL Pharmaceuticals Healthcare Deals and Alliances Profile Report...
SummaryTxcell SA Txcell is a biotechnology company that develops and innovates cellbased immunotherapy utilizing antigen specific regulatory Tcells. The company's pipeline products include cartreg...
View ArticleRP Management LLC Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryRP Management LLC RP Management is a life sciences financing company which offers biopharmaceutical products. Its products portfolio includes rituxan atripla thalomid myozyme lexiscan januvia...
View ArticleCD4 T cells xenobiotic transporters and metabolites in inflammatory bowel...
Osaka University Few studies have investigated the interaction between intestinal T cells with metabolites. Researchers have now shown in mice CD4 T effector Teff cells upregulate the protein Mdr1 in...
View ArticleElectronic nose developed to sniff out colon diseases
In much the same way as dogs can be trained to detect some diseases through their keen sense of smell technology can help create electronic devices capable of performing this same task. This is...
View ArticleScientists create electronic nose for detecting colonrelated disorders
A team of Spanish researchers developed a device called the Moosy 32 eNose for detecting ulcerative colitis Crohn's disease More
View ArticleCelgene Takes a $411M Hit From Discontinuation of Crohn's Disease Trials
The exact amount of the net pretax charge to earnings was not determined but was estimated to be in the range of $300 million to $500 million.
View ArticleOncobiologics Inc ONS Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryOncobiologics Inc Oncobiologics is a biopharmaceutical company that develops and markets biosimilar therapeutics. The company's product pipeline comprises ONS3010 and ONS1045. It uses...
View ArticleCrohns disease patient had actually swallowed a Heinz sauce sachet Evening...
Evening StandardCrohn's disease patient had actually swallowed a Heinz sauce sachetEvening StandardA woman who believed she had a serious bowel condition for six years had actually just swallowed a...
View ArticleWoman diagnosed with bowel disease for six years had a HEINZ SAUCE SACHET...
Daily MailWoman diagnosed with bowel disease for six years had a HEINZ SAUCE SACHET piercing her intestineDaily MailA woman thought she was suffering from a serious bowel disease for six years before...
View ArticleTNFalpha Inhibitors Do Not Limit Osteoporosis in Crohn's Disease
Patients with Crohn's disease CD develop similar rates of osteoporosis osteopenia and normal bone density whether or not they are treated with TNFalpha inhibitors researchers report. Reuters Health...
View Article